Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 30, 2025 • 4:01 PM ET

Date/Time Source News Release
03/04/2025 07:00 AM EST GlobeNewswire Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights
02/26/2025 07:00 AM EST GlobeNewswire Passage Bio to Participate in Upcoming Investor Conferences
01/10/2025 07:00 AM EST GlobeNewswire Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates
11/13/2024 07:00 AM EST GlobeNewswire Passage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
11/06/2024 07:00 AM EST GlobeNewswire Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference
10/24/2024 07:00 AM EDT GlobeNewswire Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference
Page
  • 1

Additional News

As of April 30, 2025 • 4:01 PM ET

Date/Time Source News Release
03/07/2025 12:00 PM EST Zacks Passage Bio (PASG) Upgraded to Buy: Here's What You Should Know
03/04/2025 07:14 AM EST SeekingAlpha Passage Bio GAAP EPS of -$1.07 misses by $0.12
03/03/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Monday, March 3rd, 2025
03/03/2025 04:30 AM EST US Earnings Reports Expected earnings - Passage Bio Inc.
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Passage Bio Inc.
11/13/2024 08:17 AM EST SeekingAlpha Passage Bio GAAP EPS of -$0.31 misses by $0.08
Page
  • 1